Japan Q2 Roundup: Mixed Bag For Majors But Forex Provides Boost

 
• By Lisa Takagi
  
Quarterly financial results by Five Japanese firms showed high forex impacts with contrasting R&D view.
Japan's major pharma firms benefit from weak yen in latest quarter • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia